✦ LIBER ✦

Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease

✍ Scribed by Kevin Z Qu; Ke Zhang; Wanlong Ma; Hairong Li; Xiuqiang Wang; Xi Zhang; Francis Giles; Michelle Lai; Nezam H Afdhal; Maher Albitar

Book ID: 108953898
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 310 KB
Volume: 26
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2010.06491.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surgery for hepatocellular carcinoma in

Surgery for hepatocellular carcinoma in patients with chronic liver disease

✍ D. Cherqui 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Diagnosis of liver nodules observed in c

Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma

✍ Eugenio Caturelli; Francesca Bartolucci; Elisabetta Biasini; Maria Luigia Viglio 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 327 KB

Hepatocellular carcinoma in patients wit

Hepatocellular carcinoma in patients with chronic liver disease: A comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT

✍ C.-K. Baek; J.-Y. Choi; K.-A. Kim; M.-S. Park; J.S. Lim; Y.E. Chung; M.-J. Kim; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 816 KB

Risk factors for hepatocellular carcinom

Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study

✍ Nghi B. Ha; Nghiem B. Ha; Aijaz Ahmed; Walid Ayoub; Tami J. Daugherty; Ellen T. 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 196 KB

Identification of a new marker of hepato

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

✍ Valérie Paradis; Francoise Degos; Delphine Dargère; Nanou Pham; Jacques Belghiti 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) is a proteomic technique that enables the profiling of proteins present in any biological material studied. We used this approach to identify new biomarkers of hepatocellular carcinoma (HCC) in the sera of p

Metformin and reduced risk of hepatocell

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

✍ Valter Donadon; Massimiliano Balbi; Maria Dal Mas; Pietro Casarin; Giorgio Zanet 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB